AWM
CYTK icon

Activest Wealth Management’s Cytokinetics CYTK Stock Holding History

Activest Wealth Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28K Sell
15
-5
-25% -$359 ﹤0.01% 918
2026
Q1 		$1.32K Buy
20
+1
+5% +$64 ﹤0.01% 998
2025
Q4 		$1.21K Hold
19
– – ﹤0.01% 932
2025
Q3 		$1.04K Buy
19
+1
+6% +$41 ﹤0.01% 872
2025
Q2 		$595 Buy
+18
New +$626 ﹤0.01% 841

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Activest Wealth Management's CYTK Position: Q2 2026 in Review

Activest Wealth Management reduced its Cytokinetics (CYTK) stake by 25% in Q2 2026, selling an estimated $359 and leaving 15 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #918.

Activest Wealth Management first reported a position in CYTK in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.32K in Q1 2026. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Activest Wealth Management held 15 shares of Cytokinetics worth $1.28K as of Q2 2026.
  • Activest Wealth Management sold 5 Cytokinetics shares in Q2 2026, an estimated $359.
  • Cytokinetics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #918 holding.
  • Activest Wealth Management first reported a position in Cytokinetics in Q2 2025 and has held it in 5 quarters since.
  • Activest Wealth Management's Cytokinetics position peaked at $1.32K in Q1 2026.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.